(S)-9-((tert-Butyldimethylsilyl)oxy)-4,11-diethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

98%

Reagent Code: #237976
fingerprint
CAS Number 1023758-14-6

science Other reagents with same CAS 1023758-14-6

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 506.67 g/mol
Formula C₂₈H₃₄N₂O₅Si
inventory_2 Storage & Handling
Storage 2-8°C, Sealed, Dry, Light-proof, Inert Gas

description Product Description

Used in the synthesis of camptothecin analogs, which are potent anticancer agents targeting topoisomerase I. This compound is a key intermediate featuring a tert-butyldimethylsilyl (TBS) protecting group at the 9-position, which enhances lipophilicity and facilitates synthetic manipulations while preserving the core structure for developing stable lactone forms. Commonly employed in medicinal chemistry to create derivatives with improved solubility, pharmacokinetic properties, and efficacy against solid tumors such as lung, colon, and breast cancers.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿8,640.00
inventory 250mg
10-20 days ฿14,670.00
inventory 1g
10-20 days ฿48,580.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
(S)-9-((tert-Butyldimethylsilyl)oxy)-4,11-diethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
No image available

Used in the synthesis of camptothecin analogs, which are potent anticancer agents targeting topoisomerase I. This compound is a key intermediate featuring a tert-butyldimethylsilyl (TBS) protecting group at the 9-position, which enhances lipophilicity and facilitates synthetic manipulations while preserving the core structure for developing stable lactone forms. Commonly employed in medicinal chemistry to create derivatives with improved solubility, pharmacokinetic properties, and efficacy against solid

Used in the synthesis of camptothecin analogs, which are potent anticancer agents targeting topoisomerase I. This compound is a key intermediate featuring a tert-butyldimethylsilyl (TBS) protecting group at the 9-position, which enhances lipophilicity and facilitates synthetic manipulations while preserving the core structure for developing stable lactone forms. Commonly employed in medicinal chemistry to create derivatives with improved solubility, pharmacokinetic properties, and efficacy against solid tumors such as lung, colon, and breast cancers.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...